All right. Thanks, Jay. All right, in the next few minutes, I'm going to provide some details of our financial performance in the 2023 first quarter but I would -- all right. Now let me take a minute to highlight a new chart we added to the press release, and which includes -- we're going to include each quarter going forward. It provides eight quarters of trailing 12-month historical data and four key metrics cited earlier, sales, gross profit, gross margin and EBITDA. So I wanted to add this chart because we know there are individual quarters that can be affected by outside factors and these might include timing fluctuations, customer shipments, supply chain issues. Any of these during a given reporting cycle could temporarily disrupt our momentum. Nortech also reported numerous nonrecurring items in 2020 and 2021, including PPP loan forgiveness, a gain on sale and leaseback, goodwill impairment and other items. Those nonrecurring items are listed in our press release, and they are excluded from our adjusted gross profit, gross margin and EBITDA. The LTM charts also show a dramatic turnaround from our lowest quarter in Q1 of 2021, two years ago. At that time, our LTM revenue was $99 million, gross profit was $8 million, gross margin was 8.1% and EBITDA was negative $2.3 million. For the 12 months just ended March of 2023, our revenue is now $138 million, gross profit is $22 million, gross margin is 15.8% and EBITDA is $6.7 million. Nortech's finances are healthier on every metric. All right, switching gears to this quarter's financial performance. As Jay noted, progress was made on several key performance areas with quarterly revenue up nearly 14% from the prior year period. Again, we're particularly pleased with this revenue momentum as the quarter's year-over-year growth continues and comes on a strong prior year comparable. We also saw sustainable year-over-year backlog levels, year-over-year gross margin expansion of 256 basis points and solid growth in net income and EBITDA. In the quarter, revenue totaled $34.9 million. This is a 13.6% increase on revenue of $30.7 million in the first quarter of 2021 -- sorry, 2022 and was in line with our prior quarter, as I mentioned earlier. The first quarter revenue was driven by growth in our medical and industrial categories. In the first quarter, the medical category was up $6.1 million or 40% as compared to 2022 with the majority of the increase coming from medical component products. And in the first quarter, revenue in the industrial market was up $800,000 or 9% from the prior year. Our quarterly gross profit totaled $5.5 million or 15.7% gross margin compared to a gross profit of $4 million or 13.1% in the prior year quarter. First quarter operating expenses totaled $4.4 million, a 14% increase from the first quarter operating expenses of $3.9 million and flat on a sequential basis. During the quarter, general and administrative costs increased by $500,000 primarily driven by investments in IT and HR systems. Net income totaled $681,000 or $0.23 per diluted share in Q1, up from net income of $138,000 or $0.05 per diluted share in Q1 of 2022. I also do have good news to add about our employee retention credit payments. So in December, we did receive our first payment on the ERC. And at March 31, 2023, on the balance sheet, we did have a receivable of $2.7 million, and we are pleased to report that, that second IRS payment did arrive on May 1, so we'll report that cash inflow net of $1.2 million in deferred payroll tax payments in our Q2 results. Moving on to the rest of the balance sheet and the cash flow statement. In the first quarter of 2023, cash provided by operating activities was $1.7 million compared to $1.5 million in the prior year period. During the quarter, decreases in working capital due to increased shipments drove positive operating cash flow. Inventory levels declined to $21.3 million, down from $22.4 million in the prior quarter due to less pressure to respond to global supply chain challenges. Receivables on March 31 were $16 million, relatively flat to the prior quarter. And we ended the first quarter of 2023 with $5.8 million of borrowings and $5.9 million availability on our $16 million line of credit with Bank of America. At March 31, 2023, cash and cash equivalents totaled $2.6 million, about flat to the prior quarter. We believe that our existing financing arrangements and anticipated cash flows from operations will be sufficient to satisfy our working capital needs in 2023 as well as any capital expenditures and debt repayments. We believe we have created a solid financial base to take this company into the future. So on a final note, let me reiterate our top financial priorities in 2023. They're winning new business bookings, expanding gross margins, growing EBITDA and strengthening our balance sheet. We believe we will create shareholder value through these actions by delivering sustainable free cash flow growth. Our last eight quarters of year-over-year results demonstrates that our approach is working. And with that, I will turn it back over to Jay for his closing comments.